Ionis Pharmaceuticals/$IONS
About Ionis Pharmaceuticals
Ticker
Industry
Employees
IONS Metrics
$5.5B
-
-$2.46
0.35
-
Price and volume
Market cap
$5.5B
Beta
0.35
52-week high
$52.49
52-week low
$31.40
Average daily volume
1.6M
Financial strength
Current ratio
8.911
Quick ratio
8.238
Long term debt to equity
293.202
Total debt to equity
327.644
Interest coverage (TTM)
-3.87%
Management effectiveness
Return on assets (TTM)
-7.24%
Return on equity (TTM)
-73.42%
Valuation
Price to revenue (TTM)
6.315
Price to book
8.28
Price to tangible book (TTM)
8.28
Price to free cash flow (TTM)
-13.555
Growth
Revenue change (TTM)
30.60%
Earnings per share change (TTM)
-14.26%
3-year revenue growth (CAGR)
6.73%
3-year earnings per share growth (CAGR)
-17.14%
What the Analysts think about IONS
Analyst Ratings
IONS Financial Performance
Income Statement
Q3 24
QoQ growth
$37B
-39.75%
$45B
107.52%
37.65%
6.78%
IONS Earnings Performance
Earnings per share (EPS)
Q4 23
Q1 24
Q2 24
Q3 24
Q4 24
$3.69
$2.85
$2.45
$2.42
-
$3.55
$2.61
$2.05
$2.31
$3.94
3.94%
9.20%
19.51%
4.63%
-
IONS News
What’s the current market cap for Ionis Pharmaceuticals stock?
What is the P/E ratio for Ionis Pharmaceuticals stock?
Does Ionis Pharmaceuticals stock pay dividends?
No, Ionis Pharmaceuticals (IONS) stock does not pay dividends to its shareholders as of January 27, 2025.
When is the next Ionis Pharmaceuticals dividend payment date?
Ionis Pharmaceuticals (IONS) stock does not pay dividends to its shareholders.
What is the beta indicator for Ionis Pharmaceuticals?
Ionis Pharmaceuticals (IONS) has a beta rating of 0.35. This means that it is less volatile than the market, on average. A beta of 1 would indicate the stock moves in-line with the market, while a beta of 0.5 would mean it moves half as much as the market.